Role of chemokines in melanoma progression;Papel de las quimiocinas en la progresión del melanoma

Actas Dermo-Sifiliograficas

Volumn 102, Issue 7, 2011, Pages 498-504

  Monteagudo, C ^a   Pellin Carcelen A ^a   Martin J M ^a   Ramos, D ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Chemokines; Melanoma; Metastasis; Receptors

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; CASE REPORT; CELL MIGRATION; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; MELANOMA; MELANOMA CELL; METASTASIS; MOLECULAR INTERACTION; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 79961136433     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2011.03.004     Document Type: Article

References (61)

1. S. Kuphal, and A. Bosserhoff Recent progress in understanding the pathology of malignant melanoma J Pathol 219 2009 400 409
2. A. Richmond, J. Yang, and Y. Su The good and the bad of chemokines/chemokine receptors in melanoma Pigment Cell Melanoma Res 22 2009 175 186
3. G. Lazennec, and A. Richmond Chemokines and chemokine receptors: new insights into cancer-related inflammation Trends Mol Med 16 2010 133 144
4. A. Müller, B. Homey, H. Soto, N. Ge, D. Catron, and M.E. Buchanan Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56 (Pubitemid 32225831)
5. F. Balkwill Cancer and the chemokine network Nat Rev Cancer 4 2004 540 550 (Pubitemid 38868623)
6. T. Tanaka, Z. Bai, Y. Srinoulprasert, B.G. Yang, H. Hayasaka, and M. Miyasaka Chemokines in tumor progression and metastasis Cancer Sci 96 2005 317 322 (Pubitemid 41007465)
7. M.M. Robledo, R.A. Bartolomé, N. Longo, J.M. Rodríguez- Frade, M. Mellado, and I. Longo Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells J Biol Chem 276 2001 45098 45105
8. M. Thelen, and J.V. Stein How chemokines invite leukocytes to dance Nat Immunol 9 2008 953 959
9. E.A. Clark, T.R. Golub, E.S. Lander, and R.O. Hynes Genomic analysis of metastasis reveals an essential role for RhoC Nature 406 2000 532 535 (Pubitemid 30625739)
10. P.E. Van den Steen, P. Proost, A. Wuyts, J. Van Damme, and G. Opdenakker Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alfa and leaves RANTES and MCP-2 intact Blood 96 2000 2673 2681
11. R.A. Bartolomé, B.G. Gálvez, N. Longo, F. Baleux, G.N. Van Muijen, and P. Sánchez-Mateos Stromal cell-derived factor-1α promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities Cancer Res 64 2004 2534 2543 (Pubitemid 38523910)
12. R.A. Bartolomé, S. Ferreiro, M.E. Miquilena-Colina, L. Martínez-Prats, M.L. Soto-Montenegro, and D. García-Bernal The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs Am J Pathol 174 2009 602 612
13. I.J. Fidler The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited Nature Rev Cancer 3 2003 453 458 (Pubitemid 37328849)
14. S. Paget The distribution of secondary growths in cancer of the breast Lancet 1 1889 571 573
15. C.M. Balch, J.E. Gershenwald, S.J. Soong, J.F. Thompson, M.B. Atkins, and D.R. Byrd Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
16. L. Liotta An attractive force in metastasis Nature 410 2001 24 25 (Pubitemid 32225818)
17. A. Peled, I. Petit, O. Kollet, M. Magid, T. Ponomaryov, and T. Byk Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4 Science 283 1999 845 848
18. T. Schioppa, B. Uranchimeg, A. Saccani, S.K. Biswas, A. Doni, and A. Rapisarda Regulation of the chemokine receptor CXCR4 by hypoxia J Exp Med 198 2003 1391 1402 (Pubitemid 37392484)
19. B. Guleng, K. Tateishi, M. Ohta, F. Kanai, A. Jazag, and H. Ijichi Blockade of the stromal cell-derived factor/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner Cancer Res 65 2005 5864 5871 (Pubitemid 40911192)
20. A. Orimo, P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, and R. Naeem Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 2005 335 348 (Pubitemid 40692295)
21. T. Murakami, W. Maki, A.R. Cardones, H. Fang, A. Tun Kyi, and F.O. Nestle Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells Cancer Res 62 2002 7328 7334 (Pubitemid 36025256)
22. R. Forster, L. Ohl, and G. Henning Lessons learned from lymphocytes: CC chemokine receptor-7 involved in lymphogenic metastasis of melanoma J Natl Cancer Inst 93 2001 1588 1589 (Pubitemid 33094859)
23. H.E. Wiley, E.B. González, W. Maki, M.T. Wu, and S.T. Hwang Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma J Natl Cancer Inst 93 2001 1638 1643 (Pubitemid 33094871)
24. H. Takeuchi, A. Fujimoto, M. Tanaka, T. Yamano, E. Hsueh, and D.S. Hoon CCL21 chemokine regulates receptor CCR7 bearing malignant melanoma cells Clin Cancer Res 10 2004 2351 2358 (Pubitemid 38445693)
25. V. Carrire, R. Colisson, C. Jiguet-Jiglaire, E. Bellard, G. Bouche, and T. Al Saati Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node Cancer Res 65 2005 11639 11648 (Pubitemid 41821724)
26. D. Blecker, S. Abraham, E.E. Furth, and M.L. Kochman Melanoma in the gastrointestinal tract Am J Gastroenterol 94 1999 3427 3433
27. F.F. Amersi, A.M. Terando, Y. Goto, R.A. Scolyer, J.F. Thompson, and A.N. Tran Activation of CCR9 / CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine Clin Cancer Res 14 2008 638 645 (Pubitemid 351231142)
28. S. Izraely, A. Klein, O. Sagi-Assif, T. Meshel, G. Tsarfaty, and D.S. Hoon Chemokine-chemokine receptor axes in melanoma brain metastasis Immunol Lett 130 2010 107 114
29. H. Kang, R.E. Mansel, and W.G. Liang Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells Int J Oncol 26 2005 1429 1434
30. J.D. Shields, M.E. Fleury, C. Yong, A.A. Tomei, G.J. Randolph, and M.A. Swartz Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling Cancer Cell 11 2007 526 538 (Pubitemid 46856909)
31. S. Singh, A.P. Singh, B. Sharma, L.B. Owen, and R.K. Singh CXCL8 and its cognate receptors in melanoma progression and metastasis Future Oncol 6 2010 111 116
32. A. Mantovani, R. Bonecchi, and M. Locati Tuning inflammation and immunity by chemokine sequestration: decoys and more Nat Rev Immunol 6 2006 907 918 (Pubitemid 44851733)
33. Z.G. Fridlender, J. Sun, S. Kim, V. Kapoor, G. Cheng, and L. Ling Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN Cancer Cell 16 2009 183 194
34. M.A. Lowes, G.A. Bishop, K. Crotty, R.C. Barnetson, and G.M. Halliday T Helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas J Invest Dermatol 108 1997 914 919 (Pubitemid 27272409)
35. F.F. Antonicelli, J. Lorin, S. Kurdykowski, S.C. Gangloff, R. Le Naour, and J.M. Sallenave CXCl10 reduces melanoma proliferation and invasivity in vitro and in vivo Br J Dermatol 164 2011 720 728
36. P. Romagnani, L. Maggi, B. Mazzinghi, L. Cosmi, L. Lasagni, and F. Liotta CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production J Allergy Clin Immunol 116 2005 1372 1379 (Pubitemid 41740951)
37. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow Lancet 357 2001 539 545
38. A. Pivarcsi, A. Müller, A. Hippe, J. Rieker, A. van Lierop, and M. Steinhoff Tumor immune escape by the loss of homeostatic chemokine expression P Natl Acad Sci USA 104 2007 19055 19060
39. J. Jaeger, D. Koczan, H.J. Thiesen, S.M. Ibrahim, G. Gross, and R. Spang Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues Clin Cancer Res 13 2007 806 815 (Pubitemid 46340353)
40. T. Murakami, A.R. Cardones, S.E. Finkelstein, N.P. Restifo, B.A. Klaunberg, and F.O. Nestle Immune evasion by murine melanoma mediated through chemokine receptor-10 J Exp Med 198 2003 1337 1347 (Pubitemid 37392479)
41. O. Simonetti, G. Goteri, G. Lucarini, A. Filosa, T. Pieramici, and C. Rubini Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape Eur J Cancer 42 2006 1181 1187
42. W. Zou, V. Machelon, A. Coulomb-L'Hermin, J. Borvak, F. Nome, and T. Isaeva Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells Nature Med 7 2001 1339 1346 (Pubitemid 34007939)
43. K. Dunussi-Joannopoulos, K. Zuberek, K. Runyon, R.G. Hawley, A. Wong, and J. Erickson Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses Blood 100 2002 1551 1558 (Pubitemid 34925126)
44. T. Zhang, R. Somasundaram, K. Berencsi, L. Caputo, P. Rani, and D. Guerry CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture J Immunol 174 2005 5856 5863 (Pubitemid 40593231)
45. J.D. Shields, I.C. Kourtis, A.A. Tomei, J.M. Roberts, and M.A. Swartz Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21 Science 328 2010 749 752
46. K. Kawada, M. Sonoshita, H. Sakashita, A. Takabayashi, Y. Yamaoka, and T. Manabe Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes Cancer Res 64 2004 4010 4017 (Pubitemid 38697317)
47. S. Amatschek, R. Lucas, A. Eger, M. Pflueger, H. Hundsberger, and C. Knoll CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells Br J Cancer 104 2011 469 479
48. S. Scala, A. Ottaiano, P.A. Ascierto, M. Cavalli, E. Simeone, and P. Giuliano Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma Clin Cancer Res 11 2005 1835 1841 (Pubitemid 40471847)
49. M.I. Longo-Imedio, N. Longo, I. Treviño, P. Lázaro, and P. Sanchez-Mateos Clinical significance of CXCR3 and CXCR4 expression in primary melanoma Int J Cancer 117 2005 861 865 (Pubitemid 41598840)
50. C. Monteagudo, J.M. Martin, E. Jorda, and A. Llombart-Bosch CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors J Clin Pathol 60 2007 596 599 (Pubitemid 46975211)
51. I.M. Mullins, C.L. Slingluff, J.K. Lee, C.F. Garbee, J. Shu, and S.G. Anderson CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease Cancer Res 64 2004 7697 7701 (Pubitemid 39446899)
52. J.C. Acosta, and J. Gil A role for CXCR2 in senescence, but what about in cancer? Cancer Res 69 2009 2167 2170
53. L. Terradez, N. Santonja, and C. Monteagudo CXCR2 expression and progression of cutaneous melanoma Virchows Archiv 452 2008 S256
54. S. Singh, K.C. Nannuru, A. Sadanandam, M.L. Varney, and R.K. Singh CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion Br J Cancer 100 2009 1638 1646
55. D. Ilkovitch, and D.M. López Immune modulation by melanoma-derived factors Exp Dermatol 17 2008 977 985
56. M. Kochetkova, S. Kumar, and S.R. McColl Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells Cell Death Differ 16 2009 664 673
57. J. Juárez, L. Bendall, and K. Bradstock Chemokines and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis Curr Pharm Res 10 2004 1245 1259 (Pubitemid 38425904)
58. M. Takenaga, H. Tamamura, K. Hiramatsu, N. Nakamura, Y. Yamaguchi, and A. Kitagawa A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma Biochem Biophys Res Commun 320 2004 226 232 (Pubitemid 38781805)
59. V.O. Melnikova, and M. Bar-Eli Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8 Pigment Cell Res 19 2006 395 405 (Pubitemid 44326401)
60. U. Thanarajasingam, L. Sanz, R. Diaz, J. Qiao, L. Sánchez- Pérez, and T. Kottke Delivery of CCL21 to metastatic disease improves the efficacy of adoptive T-cell therapy Cancer Res 67 2007 300 308 (Pubitemid 46142788)
61. S. Lanati, D.B. Dunn, M. Roussigné, M.S. Emmett, V. Carriere, and D. Jullien Chemotrap-1: an engineered soluble receptor that blocks chemokine-induced migration of metastatic cancer cells in vivo Cancer Res 70 2010 8138 8148